Evidence map›Paper›PMID 29882894›Full record

ArticleBioengineering (Basel, Switzerland)2018

A Microfluidic System for the Investigation of Tumor Cell Extravasation.

Claudia Kühlbach, Sabrina da Luz, Frank Baganz, Volker C Hass, Margareta M Mueller

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Mechano-Organ-on-Chip for Cancer Research.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. How much do we know about the metastatic process?Clinical & experimental metastasis · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. The Cancer Microenvironment: Mechanical Challenges of the Metastatic Cascade.Frontiers in bioengineering and biotechnology · 2021
    Review
  14. Review
  15. Review
  16. Review
  17. Cell Culture BasedFrontiers in bioengineering and biotechnology · 2020
    Review
  18. Review
  19. Review
  20. Advances in Micro-Bioreactor Design for Organ Cell Studies.Bioengineering (Basel, Switzerland) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Claudia KühlbachDepartment of Mechanical und Medical Engineering, Hochschule Furtwangen University, Villingen-Schwenningen 78054, Germany. kuec@hs-furtwangen.de.
Sabrina da LuzHahn-Schickard, Villingen-Schwenningen 78054, Germany, sabrina_daluz@yahoo.de. sabrina_daluz@yahoo.de.
Frank BaganzDepartment of Biochemical Engineering, University College London, London WC1E 6BT, UK. f.baganz@ucl.ac.uk.
Volker C HassDepartment of Biochemical Engineering, University College London, London WC1E 6BT, UK. volker.hass@hs-furtwangen.de.
Margareta M MuellerDepartment of Mechanical und Medical Engineering, Hochschule Furtwangen University, Villingen-Schwenningen 78054, Germany. muem@hs-furtwangen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic dissemination of cancer cells is a very complex process. It includes the intravasation of cells into the metastatic pathways, their passive distribution within the blood or lymph flow, and their extravasation into the surrounding tissue. Crucial steps during extravasation are the adhesion of the tumor cells to the endothelium and their transendothelial migration. However, the molecular mechanisms that are underlying this process are still not fully understood. Novel three dimensional (3D) models for research on the metastatic cascade include the use of microfluidic devices. Different from two dimensional (2D) models, these devices take cell⁻cell, structural, and mechanical interactions into account. Here we introduce a new microfluidic device in order to study tumor extravasation. The device consists of three different parts, containing two microfluidic channels and a porous membrane sandwiched in between them. A smaller channel together with the membrane represents the vessel equivalent and is seeded separately with primary endothelial cells (EC) that are isolated from the lung artery. The second channel acts as reservoir to collect the migrated tumor cells. In contrast to many other systems, this device does not need an additional coating to allow EC growth, as the primary EC that is used produces their own basement membrane. VE-Cadherin, an endothelial adherence junction protein, was expressed in regular localization, which indicates a tight barrier function and cell⁻cell connections of the endothelium. The EC in the device showed in vivo-like behavior under flow conditions. The GFP-transfected tumor cells that were introduced were of epithelial or mesenchymal origin and could be observed by live cell imaging, which indicates tightly adherent tumor cells to the endothelial lining under different flow conditions. These results suggest that the new device can be used for research on molecular requirements, conditions, and mechanism of extravasation and its inhibition.

Indexed as

HPAECmicrofluidic devicetumor cell extravasation

Identifiers

PMID29882894
PMCPMC6027408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.